Mayy F. Chahla

Mayy F. Chahla

Auto-generated profile, based on publicly available information

Mayy F. Chahla

Michael Eberlein, Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Chest
Verified
Journal Article
Closed access
PDF file
MEMichael Eberlein
Michael Eberlein
SPSolbert Permutt
Solbert Permutt
MCMayy F. Chahla
Mayy F. Chahla
Servet BölükbasServet Bölükbas
Servet Bölükbas
SNSteven D. Nathan
Steven D. Nathan
RBRoy G. Brower
Roy G. Brower

1 May 2012 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MEMichael Eberlein
Michael Eberlein
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
LYLonny Yarmus
Lonny Yarmus
DFDavid J Feller-Kopman
David J Feller-Kopman
RDRebecca Dezube
Rebecca Dezube
RBRoy G. Brower
Roy G. Brower

1 November 2012 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MEMichael Eberlein
Michael Eberlein
RRRobert M. Reed
Robert M. Reed
SPSolbert Permutt
Solbert Permutt
MCMayy F. Chahla
Mayy F. Chahla
Servet BölükbasServet Bölükbas
Servet Bölükbas
RBRoy G. Brower
Roy G. Brower

1 January 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MEMichael Eberlein
Michael Eberlein
SPSolbert Permutt
Solbert Permutt
RBRobert H. Brown
Robert H. Brown
ABAllison Brooker
Allison Brooker
MCMayy F. Chahla
Mayy F. Chahla
RBRoy G. Brower
Roy G. Brower
Rationale: Flow volume loops (FVL) in some bilateral lung transplant (BLT) and heart–lung transplant (HLT) patients suggest variable extrathoracic obstruction in the absence of identifiable causes. These FVLs usually have supranormal expiratory and normal inspiratory flow rates (SUPRA pattern). Objectives: Characterize the relationship of the SUPRA pattern to predicted donor and recipient lung volumes, airway size, and survival. Methods: We performed a retrospective review of adult BLT/HLT patients. We defined the SUPRA FVL pattern as: (1) mid-vital capacity expiratory to inspiratory flow ratio (Ve50:Vi50) > 1.0, (2) absence of identifiable causes of extrathoracic obstruction, and (3) Ve50/FVC ≥ 1.5 s−1. We calculated predicted total lung capacity (pTLC) ratio by dividing the donor pTLC by the recipient pTLC. We measured airway luminal areas on thoracic computer tomographic scans. We compared survival in patients with and without the SUPRA pattern. Measurements and Main Results: The SUPRA FVL pattern occurred in 56% of the 89 patients who qualified for the analysis. The pTLC ratio of SUPRA and non-SUPRA patients was 1.11 and 0.99, respectively (P = 0.004). A higher pTLC ratio was correlated with increased probability of the SUPRA pattern (P = 0.0072). Airway luminal areas were larger in SUPRA patients (P = 0.009). Survival was better in the SUPRA cohort (P = 0.009). Conclusions: The SUPRA FVL pattern was frequent in BLT/HLT patients. High expiratory flows in SUPRA patients could result from increased lung elastic recoil or reduced airway resistance, both of which could be caused by the pTLC mismatch. Improved survival in the SUPRA cohort suggests potential therapeutic approaches to improve outcomes in BLT/HLT patients.

1 January 2017 in World Journal of Transplantation
Verified
Journal Article
Open access
MEMichael Eberlein
Michael Eberlein
Robert M. ReedRobert M. Reed
Robert M. Reed
MCMayy Chahla
Mayy Chahla
Servet BölükbasServet Bölükbas
Servet Bölükbas
ABAmy Blevins
Amy Blevins
TDTobias Deuse
Tobias Deuse
To systematically review reports on deceased-donor-lobar lung transplantation (ddLLTx) and uniformly describe size matching using the donor-to-recipient predicted-total lung-capacity (pTLC) ratio. We set out to systematically review reports on ddLLTx and uniformly describe size matching using the donor-to-recipient pTLC ratio and to summarize reported one-year survival data of ddLLTx and conventional-LTx. We searched in PubMed, CINAHL via EBSCO, Cochrane Database of Systematic Reviews via Wiley (CDSR), Database of Abstracts of Reviews of Effects via Wiley (DARE), Cochrane Central Register of Controlled Trials via Wiley (CENTRAL), Scopus (which includes EMBASE abstracts), and Web of Science for original reports on ddLLTx. Nine observational cohort studies reporting on 301 ddLLTx met our inclusion criteria for systematic review of size matching, and eight for describing one-year-survival. The ddLLTx-group was often characterized by high acuity; however there was heterogeneity in transplant indications and pre-operative characteristics between studies. Data to calculate the pTLC ratio was available for 242 ddLLTx (80%). The mean pTLCratio before lobar resection was 1.25 ± 0.3 and the transplanted pTLCratio after lobar resection was 0.76 ± 0.2. One-year survival in the ddLLTx-group ranged from 50%-100%, compared to 72%-88% in the conventional-LTx group. In the largest study ddLLTx (n = 138) was associated with a lower one-year-survival compared to conventional-LTx (n = 539) (65.1% vs 84.1%, P < 0.001). Further investigations of optimal donor-to-recipient size matching parameters for ddLLTx could improve outcomes of this important surgical option.

11 March 2003 in Biochemistry
Verified
Journal Article
Closed access
MCMayy Chahla
Mayy Chahla
JWJohn Wooll
John Wooll
TLThomas M. Laue
Thomas M. Laue
NNNghia Nguyen
Nghia Nguyen
DSDonald F. Senear
Donald F. Senear